7 results on '"Pan, Lili"'
Search Results
2. Right Ventricular Function in Takayasu's Arteritis Patients With Pulmonary Artery Involvement Using MRI Feature Tracking.
- Author
-
Li, Qing, Liao, Hua, Ren, Yue, Yang, Dan, Yun, Qingping, Wang, Zhiyan, Zhou, Zhen, Li, Shuang, Lian, Jianxiu, Wang, Hui, Zhang, Lijun, Sun, Zhonghua, Pan, Lili, and Xu, Lei
- Subjects
TAKAYASU arteritis ,RIGHT ventricular dysfunction ,PEARSON correlation (Statistics) ,CARDIAC magnetic resonance imaging ,PULMONARY artery - Abstract
Background: Pulmonary artery involvement (PAI) is not rare in Takayasu arteritis (TA). Persistently elevated pulmonary arterial pressure in TA‐PAI patients leads to pulmonary hypertension (PH), and eventually cardiac death. Thus, the early detection of right ventricular dysfunction before the onset of PH is important. Purpose: To explore the potential of right ventricular global peak longitudinal and circumferential strain (RVGLS and RVGCS, respectively) in detecting right ventricular myocardial damage in TA‐PAI patients without PH. Study Type: Retrospective. Population: One hundred and six TA patients (39.6 ± 13.9 years), of whom 52 were non‐PAI and 54 were PAI patients (36 without PH and 18 with PH), along with 58 sex‐ and age‐matched healthy volunteers (HVs) (36.7 ± 13.2 years). The involved arteries were validated by aorta magnetic resonance (MR) angiography and pulmonary artery computed tomography angiography. Field Strength/Sequence: 3 T/Cine imaging sequence with a steady‐state free precession readout. Assessment: Cardiac MRI‐derived parameters measured by two radiologists independently were compared among HVs, and TA patients with and without PAI. In addition, these indices were further compared among HVs, and TA‐PAI patients with and without PH. Statistical Tests: Student's t test, one‐way ANOVA analysis, Pearson and Spearman correlation analysis, and reproducibility analysis. A P‐value of <0.05 was considered statistically significant. Results: Although the TA‐PAI patients without PH had a similar RV ejection fraction (RVEF) with HV (P = 0.348), RVGLS (non‐PH 20.6 ± 3.7% vs. HV 24.0 ± 3.1%) was significantly lower and RVGCS (non‐PH 14.8 ± 3.9% vs. HV 13.0 ± 2.7%) higher. The TA‐PAI patients with PH had significantly poorer RVGLS (PH 13.5 ± 3.8% vs. non‐PH 20.6 ± 3.7%) and RVGCS (PH 10.9 ± 3.2% vs. non‐PH 14.8 ± 3.9%) than those without PH. Data Conclusion: Right ventricular dysfunction was detected in the TA‐PAI patients without PH. MR‐feature tracking may be an effective method for detecting early cardiac damage in the TA‐PAI patients without PH. Level of Evidence: 3 Technical Efficacy: Stage 3 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population
- Author
-
Xi, Xin, Du, Juan, Liu, Jiayi, Zhu, Guangfa, Qi, Guanming, and Pan, Lili
- Published
- 2021
- Full Text
- View/download PDF
4. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.
- Author
-
Guo, Yanqiu, Du, Juan, Li, Taotao, Gao, Na, and Pan, Lili
- Subjects
BIOMARKERS ,C-reactive protein ,CONFIDENCE intervals ,IRON ,IRON in the body ,ACQUISITION of data ,RETROSPECTIVE studies ,TAKAYASU arteritis ,DIETARY supplements ,TREATMENT effectiveness ,COMPARATIVE studies ,ANEMIA ,MEDICAL records ,DESCRIPTIVE statistics ,BLOOD sedimentation ,RESEARCH funding ,IMMUNOSUPPRESSIVE agents ,BODY mass index ,DISEASE remission ,LONGITUDINAL method ,SYMPTOMS ,EVALUATION - Abstract
Background: Anaemia is a common clinical manifestation observed in Takayasu's arteritis (TAK), but few studies have been conducted. This study investigated whether improvement of inflammatory indicators was associated with improvement of anaemia in TAK. We also investigated whether iron supplement treatment could benefit in addition to immunosuppressant therapy in the anaemia patients with TAK. Methods: This was a retrospective cohort study of 160 patients diagnosed with TAK. All patients were further assigned into anaemia group (67 cases) or non‐anaemia group (93 cases) according to their haemoglobin levels. Fifty two anaemia patients completed follow‐up (median 5.2 months). Results: There were 67 (41.88%) anaemia patients among all 160 TAK patients. Compared to TAK patients without anaemia, the average age [32 (24, 45) vs. 40 (31, 48), p = 0.002], disease duration [36 (7, 120) vs. 72 (14, 162), p = 0.017] and BMI [21.43 (18.96, 23.81) vs. 22.86 (20.09, 25.81), p = 0.008] were significantly lower in TAK patients with anaemia. The levels of ESR [23 (15, 51) vs. 11 (5.5, 22), p = 0.0001] and CRP [9.33 (1.99, 27.8) vs. 1.99 (0.45, 6.68), p = 0.0001] were significantly increased in TAK patients who complicated with anaemia. After follow‐up, decrease of ESR, CRP and disease activity score (NIH and ITAS) were significantly associated with improvement of anaemia. One unit decrease of ESR and CRP, the hazard ratio of the improvement rate of anaemia was 1.02 [95% CI (1.00, 1.03); p = 0.027] and 1.04 [95% CI (1.02, 1.07); p < 0.001] respectively. One point decrease of NIH and ITAS‐A was associated with a higher probability of anaemia improvement [HR 95% CI: 1.25 (1.02, 1.41), p = 0.022, HR 95% CI: 1.62 (1.21, 2.17), p = 0.001]. These relationships were consistent between iron supplement treatment group and without iron supplement treatment group. We found no significant difference in cumulative hazard between the two groups (p = 0.692). Conclusion: Anaemia was a common complication in TAK. Decrease of ESR, CRP and disease activity score (NIH and ITAS) were significantly associated with improvement of anaemia, even after adjusting for various covariates. Moreover, these relationships were consistent between iron supplement treatment group and without iron supplement treatment group. There was no significant difference in the improvement of anaemia in patients receiving immunosuppressant therapy with or without iron supplement treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. PD-1 Deficiency in Regulatory T Cells May be Involved in the Pathogenesis of Takayasu's Arteritis.
- Author
-
Gao, Na, Li, Taoao, Cui, Wei, Zhao, Limin, Zhang, Jianghui, and Pan, Lili
- Subjects
TAKAYASU arteritis ,REGULATORY T cells ,PROGRAMMED cell death 1 receptors ,CELL populations - Abstract
Objectives: This study aims to investigate whether PD-1 expressions are abnormal in patients with TAK. Methods: PD-1 expression was analyzed by flow cytometry. Serum cytokines IL-10, IL-7, IL-2, IL-15, CCL2, CCL3, and CXCL10 were detected using a cytokine cytometric bead array. Immunohistochemistry staining analysis was used to test PD-1 and programmed death-ligand 1 (PD-L1) expression in the aorta of three patients with TAK and three patients with atherosclerosis as controls. Results: The mean fluorescence intensity of PD-1 in CD4
+ PD-1+ cells was decreased in patients with TAK and the frequency of CD4+ Foxp3-PD-1+ cells among CD4+ T cells was also decreased in peripheral blood relative to healthy controls (P < .05). The percentage of CD4+ CD25+ Foxp3+ PD-1+ cells in the CD4+ CD25+ T cell population was lower in patients with TAK than in healthy control and was lower in active TAK group (P < .05). Comparing PD-1 and PDL-1 expression in aorta tissue showed that patients with TAK tended to have lower levels than patients with atherosclerosis, but the difference was not significant (P > .05). Patients with TAK had higher serum levels of IL-10, IL-7, CCL2, and CCL3 (P < .05). Conclusions: Abnormal expression of PD-1 in serum and aorta tissue of patients with TAK may contribute to TAK pathogenesis. Key points: PD-1 expression in both peripheral blood and aorta tissue of TAK patients decreased relative to healthy controls, indicating that PD-1 might be involved in TAK pathogenesis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu's Arteritis.
- Author
-
Du, Juan, Ren, Yanlong, Liu, Jiayi, Li, Taotao, Zhang, Yaxin, Yang, Shiyu, Kang, Tieduo, Ning, Shangqiu, Chen, Liying, Guo, Xi, Liu, Wenxian, and Pan, Lili
- Subjects
TAKAYASU arteritis ,DISEASE duration ,LOGISTIC regression analysis ,OLDER patients ,ATHEROSCLEROSIS - Abstract
Background and aim: Takayasu's arteritis (TA) is a chronic inflammation that frequently involves the aorta and its major branches. It has been known that atherosclerosis can occur in some TA patients. Objectives: This study aimed to identify the risk factors associated with the development of atherosclerosis in TA. Methods: This retrospective study enrolled a total of 101 TA patients. All patients were divided into two groups according to the absence or presence of atherosclerosis. Baseline demographic features and clinical characteristics were compared between two groups. A logistic model was applied to determine the risk factors associated with the development of atherosclerosis. Results: Our data suggested that the disease duration of patients in the atherosclerosis group was significantly longer than that of patients in the non-atherosclerosis group [96(18.00, 180.00) versus 48.00(12.00, 111.00) months] (P =.015). In addition, the average age of patients with atherosclerosis was significantly older compared to patients without atherosclerosis [44.00(38.00, 48.00)versus 28.50(24.00,37.00)years] (P <.001). Logistic regression analysis showed that the risk of developing atherosclerosis increased by 9.2% per 1 year increase in the disease duration (P =.005, OR 1.092, 95%CI: 1.027-1.162). Patients with TG/HDL-C ratio more than 0.8875 were associated with a 5.861fold increase of risk developing atherosclerosis (P <.001, OR 5.861, 95%CI: 2.299-14.939). Conclusion: Our study indicated that prolonged disease duration and elevated TG/HDL-C ratio are associated with the development of atherosclerosis in TA patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The role of CD8+ Granzyme B+ T cells in the pathogenesis of Takayasu's arteritis.
- Author
-
Li, Taotao, Gao, Na, Cui, Wei, Zhao, Limin, Du, Juan, Shi, Xuemei, Zhu, Junming, Qiao, Zhiyu, Guo, Shichao, and Pan, Lili
- Subjects
TAKAYASU arteritis ,T cells ,GRANZYMES ,BLOOD cells ,B cells - Abstract
Objective: T cell-mediated immune response plays a key role in Takayasu arteritis (TAK). Although previous studies have showed the roles of CD4
+ T cell and its subsets in TAK, the change of CD8+ T cell subsets remains unclear. This study investigated the role of CD8+ T cell subsets in TAK. Methods: The study consisted of 56 TA patients and 51 healthy controls. The percentages of CD8+ T cells, CD8+ GranzymeB+ T cells, CD8+ Perforin+ T cells, and CD8+ IFN-γ+ T cells in blood samples were analyzed by flow cytometry. Results: We found that the percentages of CD8+ GranzymeB+ T cells (P = 0.030), CD8+ Perforin+ T cells (P = 0.000), and CD8+ IFN-γ+ T cells (P = 0.002) in CD8+ T cells were higher in TAK patients compared to control group. After 6 months of treatment, the proportion of CD8+ T cells in lymphocytes were significantly lower in TAK patients than the baseline assessment (P = 0.033). A lower ratio of CD8+ GranzymeB+ T cells/CD8+ T cells were showed in TAK patents after treatment compared with TAK patients before treatments (P = 0.011). The change of CD8+ GranzymeB+ T cells/CD8+ T cells ratio was positively correlated with the change of ITAS (r = 0.721, P = 0.002) and ITAS-A (r = 0.637, P = 0.008). Finally, the immunofluorescence staining showed the infiltration of CD8+ Granzyme B+ cells in the aortic tissue of TAK patients. Conclusion: Our results disclose that the CD8+ T lymphocytes may play a role in TAK pathogenesis. Targeting CD8+ GranzymeB+ T lymphocytes or Granzyme B inhibitors could be a potential therapeutic approach for the treatment of TAK. Key Points • Our study investigated role the of CD8+ T cell subsets in TAK. • We found the percentages of CD8+ GranzymeB+ T cells, CD8+ Perforin+ T cells, and CD8+ IFN-γ+ T cells in CD3+ CD8+ T cells were higher in TAK patients. • The proportion of CD8+ T cells in lymphocytes and the ratio of CD8+ GranzymeB+ T cells/CD8+ T cells were significantly lower in TAK patients after treatment. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.